April 2026 | Global Perspectives
Vigabatrin-Related Retinal Toxicity
Patients taking this medication for epilepsy should be monitored carefully for visual disturbances.
Natalia Londoño De Vivero, MD; Rafael Méndez Marulanda, MD; Daniela Rojas Pérez, MD; Clemencia De Vivero Arciniegas, MD; and Álvaro Mejía Vergara, MD
March 2026 | Global Perspectives
Using PPAR Agonists to Treat DR
This class of drugs warrants further investigation of its potential to mitigate microvascular damage and improve patient outcomes.
Tahir Ishrak Khan, MPharma, and Divya Balram Jha, MPharma
January/February 2026 | Global Perspectives
Retinal Folds Due to Vitreoretinal Traction
Look out for this uncommon yet vision-threatening complication.
Hind Safi, MD; Sarah Belghmaidi, MD, PhD; Ibtissam Hajji, MD, PhD; and Abdeljalil Moutaouakil, MD, PhD
November/December 2025 | Global Perspectives
The Need for Novel Intraocular Tamponade Agents
Surgical, diagnostic, and environmental considerations of standard tamponades reveal the potential benefits of a better solution.
Mario Romano, MD, PhD; Robert L. Avery, MD; David A. Eichenbaum, MD; and Anat Loewenstein, MD
October 2025 | Global Perspectives
DR Stability With Automated Insulin Delivery
Our study indicates the benefits of improved glycemic control outweigh the small potential risk of worsening diabetic eye disease.
Francesc March de Ribot, MD, PhD, and Ben Wheeler, MD, PhD
September 2025 | Global Perspectives
Using AI to Identify Pathologic Myopia and Myopic Maculopathy
How research on the use of AI can translate to future clinical applications.
Yining Wang, MD; Tien Yin Wong, MBBS, MMED (Ophth), MPH, PhD; and Kyoko Ohno-Matsui, MD, PhD
July/August 2025 | Global Perspectives
Creative Positioning in Vitreoretinal Surgery
A patient’s limted mobility may require accommodative solutions to provide the best possible surgical care.
Alicia Alcuaz Alcalaya, MD; Eduardo Pérez-Salvador García, MD, PhD; and María Jesús López Peña, MD, PhD
May/June 2025 | Global Perspectives
AI Chatbots in Retina
With proper foresight, this technology has the potential to enhance clinical efficiency and patient care.
Matteo Mario Carlà, MD, and Stanislao Rizzo, MD
March 2025 | Global Perspectives
Surgical Procedure for a Metallic Intraocular Foreign Body
Pearls for handling these intense cases of ocular trauma.
Jelena Potic, MD, PhD, FEBO
January/February 2025 | Global Perspectives
Membrane Peeling: Tips and Tricks
Surgical videos illustrate several intricate surgical techniques.
Hudson de Carvalho Nakamura, MD
November/December 2024 | Global Perspectives
A Sutureless Intrascleral Fixation Technique for the Carlevale IOL
No flaps, extra sclerotomies, or scleral sutures are necessary with this approach.
Eduardo Roditi, MD, and Burkhard Dick, MD, PhD, FEBOS-CR
October 2024 | Global Perspectives
Using a Mobile Fundus Camera to Evaluate Schematic Eyes
Our study suggests this method of imaging the retina is safe and effective.
Supaporn Tengtrisorn, MD; Somyot Chirasatitsin, PhD; Prawit Kaeonarong, BEng; Duangrat Gansawat, PhD; Sitthichok Chaichulee, DPHIL; and Virasakdi Chongsuvivatwong, MD, PhD
September 2024 | Global Perspectives
Purtscher-Like Retinopathy: A Warning Sign of Lupus
Retinal findings in an otherwise asymptomatic patient led to a surprising diagnosis.
Lulwa Al Matooq, MD; Zainab Al Ali, MD; and Yousef Al Dhafiri, MD
July/August 2024 | Global Perspectives
Using AI to Identify Exudative Macular Disease
A new tool for OCT interpretation was able to detect macular edema secondary to retinal pathology with high accuracy.
Claudia P. Acosta, MD; Maria Adelaida Piedrahita, MD; Juan Gonzalo Sanchez, MD; Juliana Muñoz-Ortiz, MD; Julián Martinez; José Zea; Laura Velasquez; Juliana Mesa; Sebastian Menges; and Carolina Sardi, MD, MS
April 2024 | Global Perspectives
Tailoring IVT Dosing With Vitreous Volume
We have heard the adage, “As much as necessary, as little as possible,” with regard to medication. Can we apply it to intravitreal therapy?
Andreas F. Borkenstein, MD
March 2024 | Global Perspectives
Retinal Capillary Hemangioblastomas in VHL
Case studies suggest a novel therapeutic may be able to treat these vision-threatening ocular tumors.
Corrina P. Azarcon, MD, DPBO; Imaan Zera Kherani, MD; and Amin Kherani, MD, FRCSC, FASRS
January/February 2024 | Global Perspectives
Managing The Ocular Effects of Steroid Overdose
Improper use to boost athletic performance caused this case of retinal vascular occlusion.
Fernando Godin, MD; Nimesh A. Patel, MD; Eduardo Cadena, MD; Diana Concha, MD; Maria Adelaida Piedrahita, MD; and Carolina Parra, MD
November/December 2023 | Global Perspectives
Treating Retinal Vasoproliferative Tumor
A technique using cryotherapy may be the most effective approach.
Nassim A. Abreu-Arbaje, MD, and Miguel Cruz-Pimentel, MD
View More Articles